Effect of Weight Reduction on Inflammatory Mediators in Patients with and without Metabolic Syndrome (original) (raw)
The Egyptian Journal of Hospital Medicine
Background: Obesity is now considered a low grade, chronic inflammatory disease that is associated with metabolic disorders like type 2 diabetes and insulin resistance. Weight loss in obese and overweight subjects, achieved both by energy-restricted diet or surgery, was found to be a critical factor for reducing the level of inflammatory markers. Objective: To find if the effect of weight loss on inflammatory mediators in overweight and obese patients will be affected by the presence or absence of metabolic syndrome (MetS). Methods: The final patient sample was (114) patients. According to BMI and presence or absence of MetS, they were divided into 4 groups: Group (1): overweight with MetS. Group (2): overweight without MetS. Group (3): obese with MetS. Group (4): obese without MetS. An eight-week program for weight reduction including dietary restrictions and physical activity was followed by all patients. Obesity parameters and inflammatory mediators were measured before and after weight reduction. Results: Adiponectin, TNFα and IL6 (the significantly different inflammatory mediators before the weight loss program) showed that the highest degree of significant difference was in TNFα between group 2 and 4. Delta change showed that after the weight loss program the changes were significant between the four groups in CRP, TNFα, and IL6. Group 2 and 3 were the only two groups showing significant difference in the 3 parameters. Conclusions: Presence of MetS augments the beneficial effect of weight loss in those patients in comparison to patients who lack the criteria of MetS.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.